Stocktoria

DELCATH SYSTEMS, INC. DCTH

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
1.26
Altman Z″ — distress risk · grey
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$85.2M$2.7M$73.4M$21.0M$111.2M
2024$37.2M-$26.4M$31.0M-$19.2M$68.7M
2023$2.1M-$47.7M$1.4M-$31.3M$15.8M
2022$2.7M-$36.5M$2.0M-$25.2M-$5.9M
2021$3.6M-$25.6M$2.9M-$22.7M$12.0M
2020-$24.2M$1.0M-$23.6M$22.1M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Pennell SandraChief Financial Officer2026-03-06Buy5,533$9.04
MICHEL GERARD JCHIEF EXECUTIVE OFFICER2026-03-02Buy11,200$8.96

Why these scores methodology →

Piotroski F-score: 6/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 1.26 (grey)

  • Working capital / assets 0.878
  • Retained earnings / assets -4.278
  • EBIT / assets 0.005
  • Equity / liabilities 8.96

Source: SEC EDGAR filings · CIK 0000872912 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.